Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine.

× No keyword cloud information.

6 in total

1. Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic".

Authors: Patrick McMahon; Vikash Oza; Ilona J Frieden
Journal: Pediatr Dermatol Date: 2012 Jan-Feb Impact factor: 1.588

Review 2. Periungual and subungual pyogenic granuloma.

Authors: B M Piraccini; S Bellavista; C Misciali; A Tosti; D de Berker; B Richert
Journal: Br J Dermatol Date: 2010-11 Impact factor: 9.302

Review 3. Nail toxicities induced by systemic anticancer treatments.

Authors: Caroline Robert; Vincent Sibaud; Christina Mateus; Michèle Verschoore; Cécile Charles; Emilie Lanoy; Robert Baran
Journal: Lancet Oncol Date: 2015-04 Impact factor: 41.316

4. Topical propranolol 1% cream for pyogenic granulomas of the nail: open-label study in 10 patients.

Authors: B M Piraccini; A Alessandrini; E Dika; M Starace; A Patrizi; I Neri
Journal: J Eur Acad Dermatol Venereol Date: 2015-02-23 Impact factor: 6.166

5. A pyogenic granuloma treated with topical timolol.

Authors: M Malik; R Murphy
Journal: Br J Dermatol Date: 2014-11-30 Impact factor: 9.302

Review 6. Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK.

Authors: R Califano; N Tariq; S Compton; D A Fitzgerald; C A Harwood; R Lal; J Lester; J McPhelim; C Mulatero; S Subramanian; A Thomas; N Thatcher; M Nicolson
Journal: Drugs Date: 2015-08 Impact factor: 9.546

6 in total

9 in total

1. Are topical beta-blockers really effective "in real life" for targeted therapy-induced paronychia.

Authors: Vincent Sibaud; Eline Casassa; Mirella D'Andrea
Journal: Support Care Cancer Date: 2019-03-07 Impact factor: 3.603

2. A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.

Authors: Kara D Capriotti; Milan Anadkat; Jennifer Choi; Benjamin Kaffenberger; Beth McLellan; Samuel Barone; Oluwaseun Kukoyi; Shari Goldfarb; Mario Lacouture
Journal: Invest New Drugs Date: 2019-06-26 Impact factor: 3.850

Review 3. Acute and Chronic Paronychia Revisited: A Narrative Review.

Authors: Vineet Relhan; Anuva Bansal
Journal: J Cutan Aesthet Surg Date: 2022 Jan-Mar

Review 4. Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

Authors: Daniel J Yoon; Ramanjot Kaur; Anthony Gallegos; Kaitlyn West; Hsinya Yang; Saul Schaefer; Catherine Tchanque-Fossuo; Sara E Dahle; R Rivkah Isseroff
Journal: Am J Clin Dermatol Date: 2020-11-25 Impact factor: 7.403

Review 5. Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature.

Authors: Pietro Sollena; Maria Mannino; Francesco Tassone; Maria Alessandra Calegari; Ettore D'Argento; Ketty Peris
Journal: Drugs Context Date: 2019-11-06

Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine.